Financial Avengers’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$13.2K Buy
51
+1
+2% +$256 0.01% 111
2026
Q2
$12.7K Hold
50
– – 0.01% 108
2026
Q1
$10.8K Hold
50
– – ﹤0.01% 109
2025
Q4
$11.3K Buy
50
+1
+2% +$228 ﹤0.01% 104
2025
Q3
$11.4K Hold
49
– – ﹤0.01% 105
2025
Q2
$9.06K Buy
49
+1
+2% +$186 ﹤0.01% 113
2025
Q1
$10.1K Hold
48
– – 0.01% 114
2024
Q4
$8.52K Sell
48
-129
-73% -$23.7K ﹤0.01% 129
2024
Q3
$35.1K Hold
177
– – 0.02% 78
2024
Q2
$30.4K Buy
177
+130
+277% +$21.5K 0.02% 75
2024
Q1
$8.44K Buy
47
+1
+2% +$172 ﹤0.01% 112
2023
Q4
$7.17K Hold
46
– – ﹤0.01% 128
2023
Q3
$6.82K Buy
+46
New +$6.75K ﹤0.01% 127

Other funds holding ABBV

Financial Avengers's ABBV Position: Q3 2026 in Review

Financial Avengers increased its AbbVie (ABBV) stake by 2% in Q3 2026, buying an estimated $256 and bringing the position to 51 shares worth $13.2K. The position accounts for 0.01% of the portfolio, ranked #111.

Financial Avengers first reported a position in ABBV in Q3 2023 and has held it in 13 quarters since. The position peaked at $35.1K in Q3 2024. 4,285 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Financial Avengers held 51 shares of AbbVie worth $13.2K as of Q3 2026.
  • Financial Avengers bought 1 AbbVie share in Q3 2026, an estimated $256.
  • AbbVie made up 0.01% of Financial Avengers's portfolio in Q3 2026, its #111 holding.
  • Financial Avengers first reported a position in AbbVie in Q3 2023 and has held it in 13 quarters since.
  • Financial Avengers's AbbVie position peaked at $35.1K in Q3 2024.
  • 4,285 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Financial Avengers's 13F filing for Q3 2026, filed 16 Nov 2026.